The antimicrobial resistance market is set to expand from $4.5 billion in 2023 to $11.2 billion by 2
The Antimicrobial Resistance (AMR) market encompasses the development, production, and distribution of solutions aimed at combating the resistance of microorganisms to existing antimicrobial treatments. It includes novel antibiotics, diagnostic tools, vaccines, and alternative therapies. This market addresses the urgent need for innovative approaches to manage and mitigate the global threat posed by resistant pathogens, thereby ensuring effective healthcare outcomes and safeguarding public health.